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Abstract The purple acid phosphatases (PAPs) are the
only binuclear metallohydrolases where the necessity for a
heterovalent active site [Fe(III)–M(II) (M is Fe, Zn or
Mn)] for catalysis has been established. The paradigm for
the construction of PAP biomimetics, both structural and
functional, is that the ligands possess characteristics which
mimic those of the donor sites of the metalloenzyme and
permit discrimination between trivalent and divalent metal
ions. The donor atom set of the ligand 2-((2-hydroxy-
5-methyl-3-((pyridin-2-ylmethylamino)methyl)benzyl)
(2-hydroxybenzyl)amino)acetic acid (H3HPBA) mimics
that of the active site of PAP although the iron(III) complex
of this ligand has been characterized as the tetramer
[Fe4(HPBA)2(l-CH3COO)2(l-O)(l-OH)(OH2)2]ClO45H2O.
The phosphoesterase-like activity of the complex in 1:1
acetonitrile/water has now been investigated using the
substrate 2,4-bis(dinitrophenyl)phosphate. The pH depen-
dence of the catalytic rate revealed a non-symmetric bell-
shaped profile, with a finite but non-zero rate at high pH.
Unlike the traditional approach usually employed to ana-
lyse these bell-shaped profiles, the approach used here
involved incorporating additional species which contribute
to the overall activity. Employing this approach, we show
that the complex has a kcat of 1.6 (±0.2) 9 10
-3 s-1, three
kinetically relevant pKa values of 5.3, 6.2 and 8.4, with KM
of 7.4 ± 0.6 mM. The kinetic parameters are similar to
those reported for heterovalent PAP biomimetics. Addi-
tionally, it is observed that, unlike the enzyme, the oxida-
tion state is not the determining factor for catalytic activity.
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Introduction
Purple acid phosphatases (PAPs) are the only binuclear
metallohydrolases where the necessity for a heterovalent
active site [Fe(III)–M(II) (M is Fe, Zn or Mn)] for catal-
ysis has been established [1, 2]. The enzyme isolated
from mammals (pig, bovine, mouse, rat and human) is
an approximately 35 kDa monomeric protein with an
Fe(III)–Fe(II) centre, and a characteristic purple colour
due to a charge-transfer transition (kmax = 510–560 nm;
e = *3,000–4,000 M-1 cm-1) from a conserved tyrosine
ligand to the ferric ion (Fig. 1) [3–5]. Mammalian PAPs
are easily and reversibly oxidized to the inactive diferric
form owing to the low redox potential (approximately
340 mV) of the divalent iron [6, 7], suggesting that
the PAP activity may be regulated in vivo by reversible
oxidation/reduction of the active site.
The paradigm for the construction of PAP biomimetics
is that the ligands possess characteristics such that hard and
soft coordination sites permit discrimination between the
trivalent and divalent metal ions. The ligand 2-bis[((2-
pyridylmethyl)aminomethyl)-6-((2-hydroxybenzyl)-(2-pyr-
idylmethyl))-aminomethyl]-4-methylphenol (H2BPBPMP;
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Fig. 2) is able to selectively generate heterobinu-
clear [Fe(III)(l-CH3COO)2(l-phenoxide)M(II)]
? complexes,
effectively structurally mimicking the PAP active site [8].
Phosphatase activities of the Fe(III)–M(II) (M is Mn, Co,
Ni, Cu or Zn) complexes of BPBPMP2- have been mea-
sured with the activated substrate 2,4-bis(dinitrophenyl)
phosphate (BDNPP) [9–11]. These reactions are strongly
dependent on pH, giving rise to bell-shaped pH versus rate
profiles and pH optima in the range 6.0–7.0 [10–14]. In
each case the catalytically active species is proposed to be
of the type [(OH)Fe(III)(l-OH)M(II)(OH2)] [1].
We previously reported the characterization of a tetra-
meric Fe(III) complex of the ligand 2-((2-hydroxy-
5-methyl-3-((pyridin-2-ylmethylamino)methyl)benzyl)
(2-hydroxybenzyl)amino)acetic acid (H3HPBA; Fig. 2),
[Fe4(HPBA)2(l-CH3COO)2(l-O)(l-OH)(OH2)2]ClO45H2O,
a structural mimic of the active site of PAP [15]. Although
it is believed that PAPs are only active in the heterovalent
state [16], phosphatase activity has been reported for a
number of diferric model complexes [17–23]. It was
therefore of interest to study the hydrolase activity pro-
moted by [Fe4(HPBA)2(l-CH3COO)2(l-O)(l-OH)(OH2)2]
ClO45H2O and compare that activity with the activity of
classic heterobinuclear [Fe(III)(l-CH3COO)2(l-phenoxide)
M(II)]? PAP biomimetics. In addition, we have investi-
gated a new approach to the analysis of the typical bell-
shaped pH–rate profiles reported for many biomimetic
systems [8, 9, 17–25], particularly those for which more
than two deprotonation equilibria are considered as part of
the profile [9, 13, 14].
Materials and methods
All reagents and solvents were obtained commercially and
were used without further purification.
Mass spectrometry
Low- and high-resolution positive-ion mass spectra were
obtained using a Finnigan MAT 900 XL or a Voyager DE
STR matrix-assisted laser desorption/ionization time-of-
flight (MALDI-TOF) mass spectrometer in acetonitrile/
water (1:1), pH 6.5.
Kinetic assays
Phosphatase-like activity using the activated phosphodies-
ter substrate BDNPP [26] was measured between pH 5 and
10 in acetonitrile/buffer (1:1) with a multicomponent buffer
system composed of 50 mM 2-(N-morpholino)ethanesul-
fonic acid (MES), 4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid (HEPES) and 2-(N-cyclohexylamino)
ethanesulfonic acid (CHES), with 250 mM LiClO4. Com-
plex concentrations of 20 lM were used, with 5 mM sub-
strate used in pH-dependence and complex-dependence
measurements, and a range of substrate concentrations
between 1 and 9.2 mM were employed to measure the
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Fig. 1 Active site of mammalian purple acid phosphatase (PAP).
Fe(III) binds to the high-affinity metal site M2 and Fe(II) is bound to
the low-affinity site M1. The seven metal-ion-coordinating residues
and the two histidines (His202 and His296) are highly conserved
among PAPs from different sources. Tyr167 forms a charge-transfer
complex with Fe(III) [1]
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substrate dependence of activity. Product formation was
determined by measuring the change in absorption at
400 nm (e = 12,100 M-1 cm-1) [13]. The initial-rate
method was employed. Assays were performed such that
the initial linear portion of the data was used for analysis.
For each assay, corrections for the rate of autohydrolysis
were applied. All data were fit using SigmaPlot [27].
Spectrophotometric titrations
Spectrophotometric experiments were performed at 24 C
with a U-1800 Hitachi spectrophotometer with 1-cm quartz
cuvettes. The absorption spectra were obtained within the
range 350–850 nm. A multicomponent buffer system was
employed over a pH range from 4.6 to 10.0 with buffer
concentrations of 50 mM for each of MES, CHES and
HEPES and a constant ionic strength of 250 mM LiClO4.
The cuvette contained 0.05 mL complex (1.57 mM in
acetonitrile), 0.5 mL buffer and 0.45 mL acetonitrile. All
experiments were therefore carried out at a final complex
concentration of 0.0789 mM in acetonitrile/water (1:1, v/v).
The absorption spectrum for acetonitrile/water (1:1, v/v) was
used as a baseline. Curve fitting of the data was completed
using the program SPECFIT [28].
Syntheses of the ligand and metal complex
The ligand 2-((2-hydroxy-5-methyl-3-((pyridine-2-ylmeth-
ylamino)methyl)benzyl)(2-hydroxybenzyl)amino)acetic acid
(H2HPBA) and the complex [Fe4(HPBA)2(l-CH3COO)2
(l-OH)(l-O)(OH2)2]ClO48H2O were prepared as described
previously [15].
Caution: care should be taken when using the potentially
explosive perchlorate anion.
Results
Solid-state structure
The structure of the complex [Fe4(HPBA)2(l-CH3COO)2
(l-OH)(l-O)(OH2)2]ClO48H2O has been described
previously [15]. In the solid state, each iron centre is
six-coordinate, with a harder chromophoric NO5 site
comprising oxygen donors from the terminal and bridging
phenolates, the carboxylate, the acetate ligand, a bridging
hydr/oxo and the tertiary amine nitrogen donor. The softer
N2O4 site has a water ligand, the bridging phenolate and
acetate ligands, the secondary amine and the pyridine
nitrogen as well as the bridging hydr/oxo. The dimers are
bridged by a l4-(OHO)
3- moiety [29–31]. On the basis of
the crystallographic, susceptibility and Mo¨ssbauer studies,
all metal ions are in the trivalent oxidation state [15].
Mass spectrometry
The MALDI-TOF mass spectrum was recorded under the
solvent conditions (1:1 acetonitrile/water, pH 6.5) used in the
kinetic studies. Under these conditions the dimeric species
[Fe(III)2(HPBA)(l-CH3COO)(H2O)2(OH)CH3CN)]
? (m/z
683) and [Fe(III)2(HPBA)(H2O)(OH)(CH3CN)(ClO4)]
?
(m/z 705) were apparent, with no evidence for the tetrameric
species.
Spectrophotometric titrations
An aqueous acetonitrile solution (1:1) of the complex was
titrated in a multicomponent buffer over the pH range 4
4.6–10.0. Distribution curves obtained by fitting the
absorbance versus pH data [28] suggested that there were
four species (Fig. 3), associated through protonation/
deprotonation equilibria, present in the solution over this
pH range with three pKa values of 4.9, 6.7 and 8.6.
Phosphatase-like kinetics
The phosphatase-like activity promoted by the [Fe4
(HPBA)4(l-CH3COO)2(l-OH)(l-O)(OH2)2]ClO4 complex
in 1:1 acetonitrile/water was measured using the substrate
BDNPP. The complex dependence of the hydrolytic
activity was measured at pH 6.5 with a BDNPP con-
centration of 5 mM. The complex dependence was linear
in the region 0–35 lM, with curvature of the plot
observed at higher complex concentrations (35–50 lM)
(Fig. 4). Subsequent analyses were undertaken at com-
plex concentrations of 20 lM, within the linear part of
the curve.
The substrate-concentration dependence of catalysis was
also measured at pH 6.5 (Fig. 5). Michaelis–Menten-type
behaviour was observed and the data were fitted using non-
linear least-squares analysis to give a Michaelis constant
(KM) of 7.4 ± 0.6 mM and Vmax = 3.23 9 10
-8 M s-1,
with kcat (Vmax/[complex]) = 1.6 ± 0.2 9 10
-3 s-1.
The dependence of catalysis on pH was measured from
pH 5 to 10, resulting in a bell-shaped pH–rate profile but
with a limiting rate at high pH (Fig. 6). The data were fit
separately to three equations (Eqs. 1, 2, 3):
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Equation 1 is the typical expression used to describe a
symmetric bell-shaped profile [32–35]. Equation 2 was
derived using a model based on the rapid-equilibrium
diprotic model [34] and describes a reaction scheme
(Fig. 7a) with two pKa values and two catalytically active
species in which the activity at high pH does not decrease
to zero and where the activity of the species at higher pH is
related to the activity of the species at optimum pH by the
constant c [34]. Equation 3 was again derived on the basis
of the rapid equilibrium model [34], but now encompassing
three pKa values and three catalytically active species
where the activity at high pH reaches a limit (Fig. 7b) [34].
The results of the fits of each equation are shown in Fig. 6.
In each case the catalytically relevant pKa values were
determined (Table 1).
Discussion
The pH dependence of the catalytic activity with the sub-
strate BDNPP displayed a bell-shaped profile with low but
significant activity above pH * 9.5 (Fig. 6). Bell-shaped
pH–rate profiles are, in the case of an enzyme with two
ionizable groups, explained in the low-pH region (below
the pH maximum) in terms of the increased hydrogen ion
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concentration driving the enzyme into inactive protonated
forms; in the high-pH region, above the pH maximum,
the enzyme is driven towards inactive deprotonated forms
[32–35]. In the case of dimeric Fe(III) biomimetic com-
plexes the profile is usually ascribed to the sequential
formation of species such as Fe(H2O)–Fe(H2O)/Fe(H2O)–
Fe(OH) and Fe(H2O)–Fe(OH)/Fe(OH)–Fe(OH) invoking
two deprotonation steps, and the kinetic data are fitted on
the basis of determining the magnitudes of the two pKa
values under the assumption that the fully deprotonated
form is inactive [8, 9, 17–25]. Other models invoking three
deprotonation steps derived from potentiometric data have
been reported, for example

OH2ð ÞFe IIIð Þ OH2ð Þ Lð ÞMB OH2ð Þ=
OHð ÞFe IIIð Þ OH2ð Þ Lð ÞMB OH2ð Þ

pKa1

OHð ÞFe IIIð Þ OH2ð Þ Lð ÞMB OH2ð Þ½ =
OHð ÞFe IIIð Þ l-OHð Þ Lð ÞMB OH2ð Þ½  pKa2
OHð ÞFe IIIð Þ l-OHð Þ Lð ÞMB OH2ð Þ½ =
OHð ÞFe IIIð Þ l-OHð Þ Lð ÞMB OHð Þ½  pKa3:
Here, L is BPBPMP2- and MB is Zn (pKa1 4.86, pKa2
6.00, pKa3 7.22), Ni (pKa1 5.3, pKa2 6.80, pKa3 8.61), Cu
(pKa1 5.25, pKa2 6.20, pKa3 7.82) or Co (pKa1 5.00, pKa2
6.58, pKa3 8.31) [9, 11, 13, 14]. In these cases the bell-
shaped pH–rate profiles were fitted such that only pKa1 and
pKa3 (the low-pH and high-pH extrema) were included in
the analysis but not pKa2, representing an intermediate
species. Furthermore, the commonly observed situation of
a limiting rate at high pH was not usually considered. The
presence of an active species obscured within a bell-shaped
pH–rate profile is not without precedence in metalloen-
zyme systems. Studies of the pH–rate profiles of Klebsiella
aerogenes and Canavalia ensiformis urease suggested that
a third catalytically relevant species was present, with a
pKa falling between the high-pH and low-pH pKa values
observed directly in the bell-shaped profiles [36, 37].
Fitting the data in the present case to an equation (Eq. 1)
usually employed for bell-shaped pH–rate profiles gave a
poor fit (Fig. 6). Considerably better fits were obtained
with equations which took account of the limiting rate
observed at high pH (Eqs. 2, 3). In each case the pKa1
calculated was constant (Table 1). The high-pH pKa (pKa3)
was consistent using Eqs. 2 and 3 (8.41 and 8.38, respec-
tively) but was overestimated with Eq. 1 (9.17); in addi-
tion, the limiting rate at high pH was poorly modelled. The
fit with Eq. 3, which accounts for three reaction pathways,
interrelated by three deprotonation steps, contributing to
the hydrolysis reaction (Fig. 7b) resulted in pKa values
(5.3, 6.2 and 8.4) in reasonable accord with the values
determined from the spectrophotometric analysis (Fig. 3).
The result suggests that in the pH range 5–10 two species
contribute to the hydrolysis, with a third being responsible
for the residual activity seen above pH * 9.5. In the
present case the use of the classic bell-shaped expression
(Eq. 1) is clearly insufficient to fit the data. In terms of the
simplest expression, clearly Eq. 2 gives an appropriate fit
to the data. However, employing an expression such as
Eq. 3 produces information about the ‘‘obscured’’ entity.
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There is considerable literature precedence for the
assignment of the pKa values [13, 14, 17–21, 23]. As
described above, the pKa of approximately 5 is assigned
to Fe(H2O)–Fe(H2O)/Fe(H2O)–Fe(OH), with pKa2 of
approximately 6.5 assigned to the deprotonation of Fe(III)–
H2O with subsequent formation of an Fe–(l-OH)-Fe
moiety [17]. pKa3 of approximately 8.4 is assigned to the
deprotonation of a water molecule bound to the second
Fe(III) [20]. The presence of the three deprotonation steps
suggests that the precursor species is of the form
[(H2O)Fe(H2O)Fe(H2O)]x
n? (x = 1 or 2), with the fully
deprotonated form responsible for the low but significant
activity above pH * 9.5 (Fig. 6) [14]. The model predicts
that at high pH the active species retains sufficient coor-
dination flexibility to permit coordination of BDNPP, but
the low rate is likely to be due to the slow exchange rate of
hydroxide at the substrate binding site. Nonetheless, the
rate at high pH is still several orders of magnitude greater
than both the spontaneous rate, and the rate for the free
Fe(III). Clearly, the nucleophilic agent promoting the
hydrolysis of the BDNPP substrate is an Fe(III)–OH
species.
Catalytically active tetrameric Fe(III) and Ni(II) com-
plexes have been reported [38, 39]. The iron complex has
been shown to be a promoter of ATP hydrolysis [38] and
the nickel complex has been investigated for its potential to
hydrolyze bis(nitrophenyl)phosphate [39]. Although 1H
NMR spectroscopy was employed to confirm the structure
of the former complex in solution, no evidence for the
composition of the catalytically active Ni(II) complex was
reported. In the present case, a number of options for the
catalytically active entity in solution can be considered,
including the intact tetramer and a dimer resulting from
cleavage of the l-OH/l-O bridges. In both cases loss of the
bridging acetates would be anticipated under the conditions
of catalysis [9, 10, 12–14, 23, 25] to form [Fe4(HPBA)2
(l-OH)(l-O)(OH2)6]
? and/or [(OH2)2Fe(HPBA)Fe(OH2)3]
3?
(Fig. 8); subsequent deprotonations would lead to [(OH2)
Fe(HPBA)(l-OH)Fe(H2O)2]
?/2?, with the Fe(H2O)–
Fe(H2O)/Fe(H2O)–Fe(OH) and Fe(H2O)–Fe(OH)/Fe(OH)–
Fe(OH) combinations necessary for catalytic activity
[17–19, 21]. Some support for the assignment of the cata-
lytically active entity being a dimer arises from the inves-
tigation of the dependence of the complex concentration on
Table 1 pKa values and coefficients derived from the fit of the pH–rate profile data and spectrophotometric titration
pKa1 pKa2 pKa3 Coefficients (Eqs. 2, 3) Rate constants (Fig. 7) (M s
-1)
Equation 1 5.29 9.17
Equation 2 5.42 8.41 V0 = k1 k1 = 1.40 9 10
-8
c = 0.28 k2 = 0.40 9 10
-8
Equation 3 5.37 6.06 8.38 V0 = k1 k1 = 1.40 9 10
-8
a = k3/k1 = 0.79 k2 = 0.40 9 10
-8
b = k2/k1 = 0.28 k3 = 1.11 9 10
-8
Spectrophotometric 4.9 6.7 8.6
pKa1 is the low-pH pKa, pKa3 is the high-pH pKa and pKa2 is ascribed to the ‘‘hidden’’ species
Fig. 8 a Proposed structure of [Fe4(HPBA)2(l-O)(l-OH)(OH2)2]
3?
and b proposed structure of [Fe2(HPBA)(OH2)5]
3? (O signifies a
water molecule) [15]
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the hydrolysis reaction. The complex-concentration
dependence was linear at low concentrations, with devia-
tion from linearity at higher complex concentrations
(Fig. 4). Similar non-linear complex-concentration depen-
dence has been observed previously for the reaction of an
Fe(III)Fe(III) complex with BDNPP [19]. In that case the
data were analysed, employing linearization by the
Lineweaver–Burk method of an expression which assumed
an initial equilibrium step to form a substrate–catalyst
complex, with a subsequent kinetic step [19]. Analysis by
the same method in the present case did not result in a
linear relationship over the range of the complex concen-
tration, suggesting more complicated, e.g. dimer–tetramer
equilibria, behaviour, being responsible for the observed
curvature. The mass-spectral evidence, the complex-con-
centration dependence and the similarity of the kinetic
parameters (KM = 7.4 ± 0.6 mM; kcat = 1.6 ± 0.2 9
10-3 s-1) with those reported for a series of dimeric
complexes (Table 2) suggest that a dimeric form of the
complex is the active entity under the catalytic conditions
[9, 12–14, 24, 25], mimicking the previously reported
forms of catalytically active species in the heterovalent
PAP model [Fe(III)Fe(II)(BPBPMP)(OH)(O)]?.
Conclusions
The question does arise, however, as to how relevant these
Fe(III) complexes are as models for the mammalian PAPs.
For the Fe(III)Fe(III) form of uteroferrin an upper limit of
less than 1% of the activity of the heterovalent form has
been determined [16], the release of the ultimate reaction
product (phosphate) being proposed as the likely candidate
for the rate-limiting step in the PAP-catalyzed reaction
[1, 18, 25, 40]. This hypothesis finds support in the relative
water exchange rates of Fe(III) and Fe(II) (102 and 106 s-1,
respectively) [41–43]. The diferric model reported here is
active and is, in some ways, a model for the oxidized PAP.
Mechanistically however, the oxidized system is indistin-
guishable from the reduced model systems, indicating that
the oxidation state of the diiron centre is only important in
the enzymic systems that are substantially faster. Since
hydrolysis is so slow in the models, the exchange of sub-
strate is not significant in catalysis.
More significant though is the analysis of the phospha-
tase activity of the complex. The more rigorous analysis of
the bell-shaped pH–rate profile proposed herein suggests
that in similar systems reported previously the analysis of
the observed bell-shaped pH–rate profiles was not suffi-
ciently thorough, particularly in those systems in which the
rate at high pH approaches a finite value.
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